N. Zhou

CAR T-cell therapy for triple-negative breast cancer: Where we are.

Y. Hu, Fang Chen, Lixin Wu, 2020, Cancer letters.

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients

Xiuxiu Xu, Yuan Liu, Taisheng Li, 2023, Frontiers in Immunology.